SCHEMBL22015524

SCHEMBL22015524

Nc1cnn2c1C(F)CCC2

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
SMPD3 Q9NY59 3/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22019799 0.79 ALOX15 (0.33)
SCHEMBL20400506 0.76 CA12 (0.32)
SCHEMBL22014776 0.75 SMPD3 (0.36) SMPD3
SCHEMBL22011823 0.75 SSTR4 (0.33)
SCHEMBL24871872 0.75
SCHEMBL24871942 0.72
SCHEMBL22858308 0.66 DRD4 (0.34)
SCHEMBL20939716 0.65 SMPD3 (0.35) SMPD3
SCHEMBL22309811 0.63 LRRK2 (0.31)
SCHEMBL20828043 0.63 LRRK2 (0.42) SMPD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020102574-A1 THE COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY NOVARTIS INFLAMMASOME RESEARCH, INC. (US) 2020-05-22 WO disclosed